CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for

Source URL: www.ctc.usyd.edu.au

• Bevacizumab
• Brain tumor
• Cancer treatments
• Glioblastoma multiforme
• Chemotherapy
• Reolysin
• Ranibizumab

LABORATORY SCIENCES Preclinical Evaluation of the Novel Small-Molecule Integrin ␣5␤1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization Grit Zahn, PhD; Dörte Vossmeyer, PhD; Roland Stragi

Source URL: www.scleracorp.com

• Medicine
• Ophthalmology
• Angiology
• Vision
• Choroidal neovascularization
• Angiogenesis
• Ranibizumab
• Macular degeneration
• Integrin
• Retinopathy
• Laser coagulation
• Retina

PRESTATIE- EN TARIEFBESCHIKKING ADD-ON RANIBIZUMAB Nummer Datum inwerkingtreding

Source URL: www.nza.nl

FOR IMMEDIATE RELEASE Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals Seasoned Executive Brings Wealth of Experience to Ophthalmic Biotechnology Pioneer, Including Leadership of SARcode Bio

Source URL: www.neurotechusa.com

• Genentech
• Ranibizumab
• Macular telangiectasia
• Retina
• Ophthalmology
• Vision
• Macular degeneration

Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca

Source URL: www.novartis.ca

• Choroidal neovascularization
• Ranibizumab
• Macular degeneration
• Vision
• Maculopathy
• Vascular endothelial growth factor
• Myopia
• Genentech
• Macular edema
• Ophthalmology
• Medicine
• Health

FOR IMMEDIATE RELEASE Aerpio Therapeutics to Present at Needham Healthcare Conference Cincinnati, OH, April 7, 2013 – Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovativ

Source URL: www.aerpio.com

• Genentech
• Health
• Medicine
• Ranibizumab
• Macular edema
• Diabetic retinopathy

FOR IMMEDIATE RELEASE Aerpio Therapeutics Initiates Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Diabetic Macular Edema Cincinnati, OH, February 13, 2014 – Aerpio Therapeutics, Inc., a clinical-stage b

Source URL: www.aerpio.com

• Vascular endothelial growth factor
• Ranibizumab
• Health
• Diabetic retinopathy
• Macular edema
• Genentech
• Retina
• Ophthalmology
• Medicine
• Angiology

PNAS PLUS Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy Savalan Babapoor-Farrokhrana,1, Kathleen Jeea,1, Brooks Puchnera, Syed Juna

Source URL: www.pnas.org

• Blindness
• Anatomy
• Vascular endothelial growth factor
• PEDF
• Diabetic retinopathy
• Ranibizumab
• Hypoxia-inducible factors
• Angiogenesis
• Bevacizumab
• Angiology
• Medicine
• Biology

FOR IMMEDIATE RELEASE Aerpio Therapeutics Closes $22M Financing --Proceeds Support Expanded Development Program for AKB-9778 and Advancement of HIF1 Activator into the Clinic-Cincinnati, OH, April 23, 2014 – Aerpio The

Source URL: www.aerpio.com

• Macular edema
• Diabetic retinopathy
• Medicine
• Ranibizumab
• Hypoxia-inducible factors
• Biology

Mother and daughter smile

Source URL: www.maculardegeneration.com.au

• Ranibizumab
• Caregiver
• Health
• Medicine
• AMD Alliance International
• Family
• Macular degeneration
• Low vision